FDA User Fee Corrections Act of 2012
Do you support it?
Want to know if it passes?
We'll email you when HR 6433 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 6433.
You're tracking HR 6433
We'll email you the moment it moves.
HR 6433 — FDA User Fee Corrections Act of 2012
Last action — Became Public Law No: 112-193.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
✓Passed House
-
✓Passed Senate
-
✓To Executive
-
6Enacted
This bill has been enacted into law. Introduced September 19, 2012. Enacted.
Summary
FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs. Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 6433 on the official United States source →Action History
-
Became Public Law No: 112-193.
-
Signed by President.
-
Presented to President.
-
Message on Senate action sent to the House.
-
Passed Senate without amendment by Unanimous Consent. (consideration: CR 9/21/2012 S6671)
-
Received in the Senate, read twice.
-
Motion to reconsider laid on the table Agreed to without objection.
-
On passage Passed without objection. (text: CR H6137-6138)
-
Considered by unanimous consent. (consideration: CR H6137-6138)
-
Committee on Energy and Commerce discharged.
-
Mr. Upton asked unanimous consent to discharge from committee and consider.
-
Referred to the House Committee on Energy and Commerce.
Sponsors
- Fred Upton · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 6433 do?
- FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs. Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.
- Who sponsors HR 6433?
- HR 6433 is sponsored by Fred Upton (R).
- What is the current status of HR 6433?
- This bill has been enacted into law. Introduced September 19, 2012. Enacted.
- Where can I track HR 6433?
- Track HR 6433 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 6433
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 6433
Last checked for changes about 16 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →